Harmony Biosciences Holdings (HRMY)

Number of days of payables

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Payables turnover		19.05	47.48	45.25	44.57	71.25	25.17	35.24	31.31	205.76	45.80	85.61
Number of days of payables	days	19.16	7.69	8.07	8.19	5.12	14.50	10.36	11.66	1.77	7.97	4.26

December 31, 2023 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 19.05
= 19.16

The number of days of payables for Harmony Biosciences Holdings Inc has shown fluctuations over the past eight quarters. In Q4 2023, the company took about 53.38 days to pay its outstanding bills, which is significantly higher compared to the previous quarter at 22.74 days. This indicates a longer period of payables turnover for the company in Q4 2023.

Looking at the trend over the past year, Q1 and Q2 of 2023 also had higher numbers of days of payables at 26.14 days and 25.05 days respectively, compared to Q4 2022 at 16.55 days. This suggests that the company may have been taking longer to settle its obligations during these periods.

Conversely, in Q3 2022, there was a notable increase in the number of days of payables to 49.29 days, indicating a potential delay in payment during that quarter. However, the payables turnover improved in Q2 2022 and Q1 2022 at 36.80 days and 42.12 days respectively, showing a more efficient management of payables during those periods.

Overall, the analysis of Harmony Biosciences Holdings Inc's number of days of payables reveals fluctuations in the company's payment practices over the past eight quarters, with periods of extended payables and improvements in payables turnover. It is essential for stakeholders to monitor these trends to assess the company's liquidity management and supplier relationships.